Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Profesionales de la salud / / / /
A Phase II Trial of Subcutaneous Amifostine and Radiation Therapy in Patients with Head and Neck Cancer (WR-B060)
Presenter: P. Anne Presenter's Affiliation: Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA Type of Session: Scientific Background Amifostine is an organic thiophosphate that protects normal tissues from the cytotoxic...
A Phase III Trial Comparing Whole-Pelvic (WP) to Prostate Only (PO) Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression (TAS): Preliminary Analysis of RTOG 9413
Presenter: M. Roach III Presenter's Affiliation: Radiation Oncology, UCSF, San Francisco, CA Type of Session: Plenary Background Many unanswered questions await definitive resolution in the treatment of prostate cancer. There has been significant...
A Prospective Study on Tumor Hypoxia Kinetics to Implement Hypoxic Imaging-Guided IMRT
Presenter: Chao, KS Presenter's Affiliation: Radiology, Washington University, St. Louis, St. Louis, MO Type of Session: Scientific Background Unsatisfactory local/regional tumor control for locally advanced cancers with radiation therapy is in part...
Cost-Utility Analysis of RTOG 90-03: Phase III Randomized Study Comparing Altered Fractionation to Standard Fractionation Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Presenter: A. Konski Presenter's Affiliation: Toledo Radiation Oncology, Hickman Cancer Center, Adrian, MI Type of Session: Scientific Background RTOG 90-03 a four-arm study that evaluated various fractionation schedules for the treatment of locally...
COX Inhibitors Markedly enhance Tumor Radiosensitization of Cultured Human Cancer Cells under Acidic Microenvironment
Presenter: T.R. Shah Presenter's Affiliation: Henry Ford Hospital Type of Session: Scientific Background Prostaglandins are synthesized by COX enzymes. These prostaglandins have been implicated in carcinogenesis, angiogenesis, invasiveness, and...
Eight Year Results in the Treatment of Keloids by HDR Brachytherapy
Presenter: B. Guix Presenter's Affiliation: Radiation Oncology, Fundacio IMOR, Barcelona, Spain Type of Session: Scientific Background Keloids form as a result of abnormal growth of scar tissue usually after injury to the skin. The incidence ranges...
Internet Utilization by Radiation Oncology Patients
Presenter: J.M. Metz Presenter's Affiliation: Radiation Oncology, University of Pennsylvania, Philadelphia, PA Type of Session: Scientific Background Millions of people use the Internet daily. It is not unreasonable to postulate that many cancer...
Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy
Presenter: C. Cheng Presenter's Affiliation: Sun Yat-Sen Cancer Center Type of Session: Scientific Background Post-mastectomy radiation is routinely given for patients with 4 or more positive lymph nodes to reduce locoregional failure. However,...
Molecular Markers of Patient Outcome in Prostate Cancer Treated with Radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x
Presenter: A. Pollack Presenter's Affiliation: UT MD Anderson Cancer Center, Houston, TX Type of Session: Scientific Background Abnormal expression of certain proteins have been found to alter the normal process of dying, or apoptosis, in cells. To...
One Year Follow-up Reveals No Difference in Quality of Life Between High Dose and Conventional Dose Radiation: A Quality of Life Assessment of RTOG 94-05
Presenter: L.A. Kachnic Presenter's Affiliation: Radiation Therapy Oncology Group Type of Session: Scientific Background Nonsurgical standard of care for esophageal cancer is concurrent chemoradiation. A survival advantage has been demonstrated...
Patterns of Local Regional Failure in Head and Neck Cancer Treated with IMRT
Presenter: Tran, BN Presenter's Affiliation: Mallinckrodt Institute of Radiology, Radiation Oncology Center, Washington University Medical Center, St. Louis, MO Type of Session: Scientific Background Intensity modulated radiation therapy allows...
PET Response is the Most Powerful Predictor of Survival after Radical Radiotherapy/Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer
Presenter: M.P. MacManus Presenter's Affiliation: Peter MacCallum Cancer Institute, East Melbourne, Australia Type of Session: Scientific Background Frequently, clinicians have difficulty interpreting CT scans and MRI's done on patients with...
Positron Emission Tomography after Three-Dimensional Conformal Radiation
Presenter: K.E. Rosenzweig Presenter's Affiliation: Memorial Sloan-Kettering Cancer Center, New York Type of Session: Scientific Background Frequently, clinicians have difficulty interpreting CT scans and MRI's done on patients with cancer,...
Preliminary Results of a Randomized Study of Tamoxifen Alone or Tamoxifen and Breast Radiation in Women over 50 Years of Age with T1/2 N0 Disease
Presenter: A. Fyles Presenter's Affiliation: Princess Margaret Hospital Type of Session: Scientific Background The standard of care for women with invasive breast cancer who were treated with lumpectomy is adjuvant radiation therapy and tamoxifen...
Selenium in the Treatment of Radiation-Associated Lymphedemas
Presenter: F. Bruns Presenter's Affiliation: Department of Radiotherapy and Radiation Oncology, University Hospital, Muenster, Germany Type of Session: Reporting Background : Lymphedema is a relatively common side effect after surgical and/or...
The Impact of Anemia on PSA Outcome following Radiation and Androgen Suppression Therapy in Patients with High-Risk Prostate Cancer
Presenter: A.V. DAmico Presenter's Affiliation: Brigham and Women's Hospital, Boston, MA Type of Session: Scientific Background It is well known that in men testosterone has a permissive effect on hemeglobin (Hb)levels in the bone marrow and on...
Treatment of Acoustic Neuroma: Stereotactic Radiosurgery vs Microsurgery
Presenter: Butler, EB Presenter's Affiliation: Baylor College of Medicine Type of Session: Scientific Background Two major treatment options are available for patients with acoustic neuroma, microsurgery and radiosurgery. The objective of this...
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults